Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AZ halts obesity drug trial, completes Ardea purchase
Pharma Times, UK
Wed, 06/20/12 - 12:32 pm
Tags:
obesity, M&A, Ardea Biosciences, AstraZeneca, AZD2820
Merck: Can 5 New Drugs Fill Singulair Gap?
Seeking Alpha
Tue, 06/19/12 - 10:21 am
Tags:
Merck, Singulair, Pfizer, AstraZeneca, Sanofi, Forest Labs, Bristol-Myers Squibb, suvorexant, Eli Lilly, Bridon, V503, Endocyte, Tredaptive
AstraZeneca, Rigel Pharmaceuticals sign license agreement for R256
Yahoo/Fly on the Wall
Tue, 06/19/12 - 10:13 am
Tags:
Rigel Pharmaceuticals, AstraZeneca, R256, JAK inhibitors
Nektar Phase III Trials At Risk
Seeking Alpha
Mon, 06/18/12 - 02:44 pm
Tags:
Nektar, NKTR-118, AstraZeneca, Enzon, opioid-induced bowel dysfunction
8 Major Healthcare Stocks Yielding At Least 3.9% With P/E Ratios Under 18
Seeking Alpha
Tue, 06/12/12 - 11:03 am
Tags:
AstraZeneca, Bristol-Myers Squibb, GSK, JNJ, Eli Lilly, Merck, Novartis, Pfizer
Winners Of ASCO 2012
Seeking Alpha
Mon, 06/11/12 - 06:19 pm
Tags:
ASCO, Arqule, Array Biopharma, Astex, AstraZeneca, Bristol-Myers Squibb, GSK, Curis, Exelixis, Pfizer, Immunogen, Seattle Genetics, Sanofi, Synta
Bristol-Myers, AstraZeneca announce results from Phase lll dapagliflozin study
Yahoo/The Fly On The Wall
Sun, 06/10/12 - 11:16 am
Tags:
Bristol-Myers Squibb, AstraZeneca, Dapagliflozin, type 2 diabetes, diabetes
Amylin Said To Draw Bids Of $25 To $29 A Share In First Round
Bloomberg
Tue, 06/5/12 - 09:39 am
Tags:
Amylin, M&A, Sanofi, AstraZeneca, Merck, Bristol-Myers Squibb
AstraZeneca bids $4bn for diabetes specialist Amylin
Telegraph, UK
Sun, 06/3/12 - 01:45 pm
Tags:
AstraZeneca, Amylin, M&A
Bristol, AstraZeneca among Amylin bidders-sources
Interactive Investor
Sun, 06/3/12 - 12:23 pm
Tags:
Bristol-Myers Squibb, AstraZeneca, Amylin, M&A
New Drug Could Be Game Changer For Sanofi
Seeking Alpha
Thu, 05/31/12 - 06:11 pm
Tags:
Sanofi, liver cancer, GSK, AstraZeneca, Bristol-Myers Squibb
New Drug Could Push AstraZeneca 20% Higher
Seeking Alpha
Thu, 05/31/12 - 09:38 am
Tags:
AstraZeneca, JNJ, Bristol-Myers Squibb, Eli Lilly, Pfizer, Sanofi, GSK
The Race For Amylin Kicks Into High-Gear
Seeking Alpha
Wed, 05/30/12 - 03:01 pm
Tags:
Amylin, M&A, AstraZeneca, Bristol-Myers Squibb, Pfizer
With Plavix gone generic, payers aim to cut Effient, Brilinta
Fierce Pharma
Wed, 05/30/12 - 11:30 am
Tags:
generics, Effient, Plavix, Brilinta, Eli Lilly, bloodthinners, AstraZeneca, Sanofi, Bristol-Myers Squibb
Who Should Buy Amylin?
Motley Fool
Tue, 05/29/12 - 04:44 pm
Tags:
M&A, Amylin, Sanofi, Merck, Bristol-Myers Squibb, Takeda, AstraZeneca
GlaxoSmithKline and AstraZeneca Invest in Antibiotic Research
PharmaLive
Tue, 05/29/12 - 04:43 pm
Tags:
antibiotic resistance, antibiotics, GSK, AstraZeneca
5 Reasons To Buy Navidea Biopharmaceuticals
Seeking Alpha
Mon, 05/21/12 - 04:37 pm
Tags:
Navidea Biopharmaceuticals, AstraZeneca
AstraZeneca looks to revive experimental drugs
Financial Times, UK
Sun, 05/20/12 - 12:34 pm
Tags:
AstraZeneca, R&D
AstraZeneca appeal against competition law breach and level of fine imposed on it (in Europe) should be rejected, legal advisor says
Out-Law
Sat, 05/19/12 - 12:19 pm
Tags:
AstraZeneca, legal
Plavix’s Loss Means Little Gain by Competing Blood Thinners
Bloomberg
Thu, 05/17/12 - 10:26 am
Tags:
Plavix, bloodthinners, patents, Sanofi, Bristol-Myers Squibb, AstraZeneca, Eli Lilly

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.